Journal of International Oncology ›› 2023, Vol. 50 ›› Issue (4): 244-247.doi: 10.3760/cma.j.cn371439-20230208-00048
• Reviews • Previous Articles Next Articles
Received:
2023-02-08
Revised:
2023-03-12
Online:
2023-04-08
Published:
2023-06-12
Contact:
Wang Hongyan, Email: Supported by:
Shi Xaioqi, Wang Hongyan. Research progress on the interaction between gut microbiota and radiation enteritis[J]. Journal of International Oncology, 2023, 50(4): 244-247.
[1] |
Araujo IK, Muñoz-Guglielmetti D, Mollà M. Radiation-induced damage in the lower gastrointestinal tract: clinical presentation, diagnostic tests and treatment options[J]. Best Pract Res Clin Gastroenterol, 2020, 48/49: 101707. DOI: 10.1016/j.bpg.2020.101707.
doi: 10.1016/j.bpg.2020.101707 |
[2] |
Zhao TS, Xie LW, Cai S, et al. Dysbiosis of gut microbiota is associated with the progression of radiation-induced intestinal injury and is alleviated by oral compound probiotics in mouse model[J]. Front Cell Infect Microbiol, 2021, 11: 717636. DOI: 10.3389/fcimb.2021.717636.
doi: 10.3389/fcimb.2021.717636 |
[3] |
Wang L, Wang X, Zhang G, et al. The impact of pelvic radiotherapy on the gut microbiome and its role in radiation-induced diarrhoea: a systematic review[J]. Radiat Oncol, 2021, 16(1): 187. DOI: 10.1186/s13014-021-01899-y.
doi: 10.1186/s13014-021-01899-y pmid: 34563216 |
[4] |
Badgeley A, Anwar H, Modi K, et al. Effect of probiotics and gut microbiota on anti-cancer drugs: mechanistic perspectives[J]. Biochim Biophys Acta Rev Cancer, 2021, 1875(1): 188494. DOI: 10.1016/j.bbcan.2020.188494.
doi: 10.1016/j.bbcan.2020.188494 |
[5] |
Roy S, Trinchieri G. Microbiota: a key orchestrator of cancer therapy[J]. Nat Rev Cancer, 2017, 17(5): 271-285. DOI: 10.1038/nrc.2017.13.
doi: 10.1038/nrc.2017.13 pmid: 28303904 |
[6] |
Sokol H, Adolph TE. The microbiota: an underestimated actor in radiation-induced lesions?[J]. Gut, 2018, 67(1): 1-2. DOI: 10.1136/gutjnl-2017-314279.
doi: 10.1136/gutjnl-2017-314279 pmid: 28473631 |
[7] |
Liu J, Liu C, Yue J. Radiotherapy and the gut microbiome: facts and fiction[J]. Radiat Oncol, 2021, 16(1): 9. DOI: 10.1186/s13014-020-01735-9.
doi: 10.1186/s13014-020-01735-9 pmid: 33436010 |
[8] |
Suzuki T. Regulation of intestinal epithelial permeability by tight junctions[J]. Cell Mol Life Sci, 2013, 70(4): 631-659. DOI: 10.1007/s00018-012-1070-x.
doi: 10.1007/s00018-012-1070-x pmid: 22782113 |
[9] |
De Ruysscher D, Niedermann G, Burnet NG, et al. Radiotherapy toxicity[J]. Nat Rev Dis Primers, 2019, 5(1): 13. DOI: 10.1038/s41572-019-0064-5.
doi: 10.1038/s41572-019-0064-5 pmid: 30792503 |
[10] |
Lu L, Li W, Chen L, et al. Radiation-induced intestinal damage: latest molecular and clinical developments[J]. Future Oncol, 2019, 15(35): 4105-4118. DOI: 10.2217/fon-2019-0416.
doi: 10.2217/fon-2019-0416 pmid: 31746639 |
[11] |
Li Y, Yan H, Zhang Y, et al. Alterations of the gut microbiome composition and lipid metabolic profile in radiation enteritis[J]. Front Cell Infect Microbiol, 2020, 10: 541178. DOI: 10.3389/fcimb.2020.541178.
doi: 10.3389/fcimb.2020.541178 |
[12] |
Jian Y, Zhang D, Liu M, et al. The impact of gut microbiota on radiation-induced enteritis[J]. Front Cell Infect Microbiol, 2021, 11: 586392. DOI: 10.3389/fcimb.2021.586392.
doi: 10.3389/fcimb.2021.586392 |
[13] |
Goldenberg JZ, Yap C, Lytvyn L, et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children[J]. Cochrane Database Syst Rev, 2017, 12(12): CD006095. DOI: 10.1002/14651858.CD006095.pub4.
doi: 10.1002/14651858.CD006095.pub4 |
[14] |
Liu MM, Li ST, Shu Y, et al. Probiotics for prevention of radiation-induced diarrhea: a meta-analysis of randomized controlled trials[J]. PLoS One, 2017, 12(6): e0178870. DOI: 10.1371/journal.pone.0178870.
doi: 10.1371/journal.pone.0178870 |
[15] |
Linn YH, Thu KK, Win NHH. Effect of probiotics for the prevention of acute radiation-induced diarrhoea among cervical cancer patients: a randomized double-blind placebo-controlled study[J]. Probiotics Antimicrob Proteins, 2019, 11(2): 638-647. DOI: 10.1007/s12602-018-9408-9.
doi: 10.1007/s12602-018-9408-9 pmid: 29550911 |
[16] |
Qiu G, Yu Y, Wang Y, et al. The significance of probiotics in preventing radiotherapy-induced diarrhea in patients with cervical cancer: a systematic review and meta-analysis[J]. Int J Surg, 2019, 65: 61-69. DOI: 10.1016/j.ijsu.2019.03.015.
doi: S1743-9191(19)30073-1 pmid: 30928672 |
[17] |
Riehl TE, Alvarado D, Ee X, et al. Lactobacillus rhamnosus GG protects the intestinal epithelium from radiation injury through release of lipoteichoic acid, macrophage activation and the migration of mesenchymal stem cells[J]. Gut, 2019, 68(6): 1003-1013. DOI: 10.1136/gutjnl-2018-316226.
doi: 10.1136/gutjnl-2018-316226 pmid: 29934438 |
[18] |
Guo H, Chou WC, Lai Y, et al. Multi-omics analyses of radiation survivors identify radioprotective microbes and metabolites[J]. Science, 2020, 370(6516): eaay9097. DOI: 10.1126/science.aay9097.
doi: 10.1126/science.aay9097 |
[19] |
Gibson GR, Hutkins R, Sanders ME, et al. Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics[J]. Nat Rev Gastroenterol Hepatol, 2017, 14(8): 491-502. DOI: 10.1038/nrgastro.2017.75.
doi: 10.1038/nrgastro.2017.75 pmid: 28611480 |
[20] |
Garcia-Peris P, Velasco C, Hernandez M, et al. Effect of inulin and fructo-oligosaccharide on the prevention of acute radiation enteritis in patients with gynecological cancer and impact on quality-of-life: a randomized, double-blind, placebo-controlled trial[J]. Eur J Clin Nutr, 2016, 70(2): 170-174. DOI: 10.1038/ejcn.2015.192.
doi: 10.1038/ejcn.2015.192 pmid: 26603881 |
[21] |
García-Peris P, Velasco C, Lozano MA, et al. Effect of a mixture of inulin and fructo-oligosaccharide on Lactobacillus and Bifidobacterium intestinal microbiota of patients receiving radiotherapy: a randomised, double-blind, placebo-controlled trial[J]. Nutr Hosp, 2012, 27(6): 1908-1915. DOI: 10.3305/nh.2012.27.6.5992.
doi: 10.3305/nh.2012.27.6.5992 pmid: 23588438 |
[22] |
Zhao Z, Cheng W, Qu W, et al. Antibiotic alleviates radiation-induced intestinal injury by remodeling microbiota, reducing inflammation, and inhibiting fibrosis[J]. ACS Omega, 2020, 5(6): 2967-2977. DOI: 10.1021/acsomega.9b03906.
doi: 10.1021/acsomega.9b03906 pmid: 32095719 |
[23] |
Uribe-Herranz M, Rafail S, Beghi S, et al. Gut microbiota modulate dendritic cell antigen presentation and radiotherapy-induced antitumor immune response[J]. J Clin Invest, 2020, 130(1): 466-479. DOI: 10.1172/JCI124332.
doi: 10.1172/JCI124332 pmid: 31815742 |
[24] |
Cui M, Xiao H, Li Y, et al. Faecal microbiota transplantation protects against radiation-induced toxicity[J]. EMBO Mol Med, 2017, 9(4): 448-461. DOI: 10.15252/emmm.201606932.
doi: 10.15252/emmm.201606932 pmid: 28242755 |
[25] |
Liu T, Su D, Lei C, et al. Treatment of radiation enteritis with fecal transplantation[J/OL]. Am Surg. (2022-06-12)[2023-01-12]. https://pubmed.ncbi.nlm.nih.gov/35695221/. DOI: 10.1177/00031348221091954.
doi: 10.1177/00031348221091954 |
[26] |
Bak SH, Choi HH, Lee J, et al. Fecal microbiota transplantation for refractory Crohn's disease[J]. Intest Res, 2017, 15(2): 244-248. DOI: 10.5217/ir.2017.15.2.244.
doi: 10.5217/ir.2017.15.2.244 pmid: 28522956 |
[27] |
Johnsen PH, Hilpüsch F, Cavanagh JP, et al. Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial[J]. Lancet Gastroenterol Hepatol, 2018, 3(1): 17-24. DOI: 10.1016/S2468-1253(17)30338-2.
doi: 10.1016/S2468-1253(17)30338-2 |
[28] |
韦丽娅, 郭智. 肠道微生物群与血液肿瘤[J]. 国际肿瘤学杂志, 2021, 48(7): 445-448. DOI: 10.3760/cma.j.cn371439-20201019-00086.
doi: 10.3760/cma.j.cn371439-20201019-00086 |
[29] |
Ding X, Li Q, Li P, et al. Fecal microbiota transplantation: a promising treatment for radiation enteritis?[J]. Radiother Oncol, 2020, 143: 12-18. DOI: 10.1016/j.radonc.2020.01.011.
doi: S0167-8140(20)30023-2 pmid: 32044171 |
[30] |
Xiao HW, Cui M, Li Y, et al. Gut microbiota-derived indole 3-propionic acid protects against radiation toxicity via retaining acyl-CoA-binding protein[J]. Microbiome, 2020, 8(1): 69. DOI: 10.1186/s40168-020-00845-6.
doi: 10.1186/s40168-020-00845-6 |
[31] |
Wang C, Xie J, Dong X, et al. Clinically approved carbon nano-particles with oral administration for intestinal radioprotection via protecting the small intestinal crypt stem cells and maintaining the balance of intestinal flora[J]. Small, 2020, 16(16): e1906915. DOI: 10.1002/smll.201906915.
doi: 10.1002/smll.201906915 |
[32] |
Li Y, Dong J, Xiao H, et al. Caloric restriction alleviates radiation injuries in a sex-dependent fashion[J]. FASEB J, 2021, 35(8): e21787. DOI: 10.1096/fj.202100351RR.
doi: 10.1096/fj.202100351RR |
[1] | Qian Xiaotao, Shi Ziyi, Hu Ge, Wu Xiaowei. Efficacy of consolidation chemotherapy after radical radiotherapy and chemotherapy for stage Ⅲ-ⅣA esophageal squamous cell carcinoma: a real-world clinical study [J]. Journal of International Oncology, 2024, 51(6): 326-331. |
[2] | Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun. Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer [J]. Journal of International Oncology, 2024, 51(6): 332-337. |
[3] | Zhang Rui, Chu Yanliu. Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota [J]. Journal of International Oncology, 2024, 51(6): 370-375. |
[4] | Gao Fan, Wang Ping, Du Chao, Chu Yanliu. Research progress on intestinal flora and non-surgical treatment of the colorectal cancer [J]. Journal of International Oncology, 2024, 51(6): 376-381. |
[5] | Qian Xiaotao, Shi Ziyi, Hu Ge. A real-world clinical study of immunocheckpoint inhibitor maintenance therapy after radical radiotherapy and chemotherapy in stage Ⅲ-ⅣA esophageal squamous cell carcinoma [J]. Journal of International Oncology, 2024, 51(3): 151-156. |
[6] | Li Shuyue, Ma Chenying, Zhou Juying, Xu Xiaoting, Qin Songbing. Progress of radiotherapy in oligometastatic non-small cell lung cancer [J]. Journal of International Oncology, 2024, 51(3): 170-174. |
[7] | Gao Xinyu, Li Zhenjiang, Sun Hongfu, Han Dan, Zhao Qian, Liu Chengxin, Huang Wei. Clinical application of MR-guided radiotherapy based on MR-linac in esophageal cancer patients [J]. Journal of International Oncology, 2024, 51(1): 37-42. |
[8] | Cui Tenglu, Lyu lu, Sun Pengfei. Application of radiotherapy combined with immunotherapy in the treatment of head and neck squamous cell carcinoma [J]. Journal of International Oncology, 2023, 50(9): 548-552. |
[9] | Guo Ciliang, Jiang Chunping, Wu Junhua. Gut microbiome and tumor immunotherapy [J]. Journal of International Oncology, 2023, 50(7): 432-436. |
[10] | Li Qingshan, Xie Xin, Zhang Nan, Liu Shuai. Research progress on the application of combining radiotherapy and systemic therapy in breast cancer [J]. Journal of International Oncology, 2023, 50(6): 362-367. |
[11] | Lyu Lu, Sun Pengfei. Gut flora and cervical cancer [J]. Journal of International Oncology, 2023, 50(6): 373-376. |
[12] | Radiation Oncology Treatment Physician Branch, Chinese Medical Doctor Association, Radiation Oncology Therapy Branch, Chinese Medical Association, Chinese Association of Radiation Therapy, China Anti-Cancer Association. Chinese experts' consensus on the application of pegylated recombinant human granulocyte colony-stimulating factor during concurrent chemoradiotherapy (2023 version) [J]. Journal of International Oncology, 2023, 50(4): 193-201. |
[13] | Xu Meng, Jiang Wei, Zhu Haitao, Cao Xiongfeng. Research progress of cancer-associated fibroblasts in tumor radiotherapy resistance [J]. Journal of International Oncology, 2023, 50(4): 227-230. |
[14] | Zhao Yongrui, Gao Ying, Chen Yidong, Xu Jiankun. Efficacy and safety of linear accelerator-based fractionated stereotactic radiotherapy for small volume brain metastases [J]. Journal of International Oncology, 2023, 50(3): 138-143. |
[15] | Huang Huayu, Gong Hongyun, Song Qibin. Influencing factors of pneumonitis in the period of thoracic radiotherapy combined with immunotherapy [J]. Journal of International Oncology, 2023, 50(2): 102-106. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||